
|Articles|January 4, 2017
FDA's Criminal Investigation Head to Leave as Trump Takes Office
January 04, 2017
Advertisement
Reuters reports that George Karavetsos, director of the Food and Drug Administration's Office of Criminal Investigations (OCI), is to leave the agency. Karavetsos has been OCI director since January 2015. The report adds that Karavestos's "last day will be Jan. 20, the day Donald Trump is sworn in as president".
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
3
Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu
4
Marty Makary Out as FDA Commissioner: Report
5




